Updated: January 20, 2026
How to Help Your Patients Find Nevanac in Stock: A Provider's Guide
Author
Peter Daggett

Summarize with AI
- Why Nevanac Access Is a Recurring Challenge
- Step 1: Send Prescriptions Early — At Least 7–10 Days Before Surgery
- Step 2: Identify High-Risk Patients for Access Difficulties
- Step 3: Build a Preferred Pharmacy List
- Step 4: Have Ready-to-Issue Alternative Prescriptions
- Step 5: Guide Uninsured Patients to Savings Programs
- Step 6: Direct Patients to medfinder
- The Bottom Line
A practical guide for ophthalmologists and eye surgery teams on how to help patients locate and fill Nevanac prescriptions before their cataract surgery in 2026.
As cataract surgery volumes continue to grow — with over 4 million procedures performed annually in the United States — ophthalmology practices are encountering a familiar frustration: patients arriving for their procedure without their prescribed eye drops. Nevanac (nepafenac 0.1%) is among the more commonly implicated medications. This guide gives your team practical, step-by-step guidance to minimize Nevanac access failures for your surgical patients.
Why Nevanac Access Is a Recurring Challenge
The access challenges with Nevanac are structural and predictable:
No generic available: Brand-only pricing ($329–$413/bottle retail) deters many community pharmacies from routine stocking
Insurance requirements: Approximately 80% of insurance plans cover Nevanac but many require prior authorization (PA) or step therapy — adding days of delay
Pharmacy stocking inconsistency: Community pharmacies may have zero units on hand; even chain pharmacies can run out before special orders arrive
Step 1: Send Prescriptions Early — At Least 7–10 Days Before Surgery
The most impactful change any ophthalmology practice can make is to send cataract surgery drop prescriptions as far in advance as possible. A 7–10 day lead time allows for:
Insurance PA initiation and completion (typically 1–5 business days for non-urgent requests)
Pharmacy sourcing and special ordering if out of stock
Time to pivot to an alternative NSAID if Nevanac is genuinely unavailable
Patient assistance program enrollment if the patient lacks coverage
Step 2: Identify High-Risk Patients for Access Difficulties
Flag patients at higher risk for medication access problems before surgery day:
Uninsured or underinsured patients who will pay cash (retail price $329–$413)
Medicare Part D patients whose plan has a formulary restriction or high-tier placement for Nevanac
Patients in rural areas with limited pharmacy options
Elderly patients who may struggle with phone calls and pharmacy navigation
Step 3: Build a Preferred Pharmacy List
Contact 3–5 pharmacies in your practice's geographic service area and verify which ones reliably stock Nevanac. Surgical center pharmacies, hospital outpatient pharmacies, and large chain pharmacies (CVS, Walgreens, Costco) tend to have the best access. Share this list with patients at the time of prescription. Update it quarterly, as stocking can change.
Step 4: Have Ready-to-Issue Alternative Prescriptions
Consider co-issuing (or having ready to send electronically) alternative NSAID prescriptions at the same time as Nevanac, with instructions to use the alternative only if Nevanac cannot be obtained. Clinically acceptable alternatives include:
Bromfenac 0.07% (generic): Once daily, generic available ($80–$200), strong evidence base
Ketorolac 0.5% (generic): Four times daily, very affordable ($15–$50), widely available
Ilevro (nepafenac 0.3%): Once daily, same active ingredient as Nevanac, may be stocked where Nevanac is not
Step 5: Guide Uninsured Patients to Savings Programs
For patients who lack insurance coverage for Nevanac, the following programs can significantly reduce or eliminate cost:
Novartis Patient Assistance Foundation: Provides Nevanac at no cost for qualifying uninsured patients with limited income. Phone: 1-800-277-2254
GoodRx / SingleCare coupons: Reduce out-of-pocket cost to approximately $323–$330 at participating pharmacies
Step 6: Direct Patients to medfinder
For patients who are struggling to locate Nevanac on their own, medfinder provides a service specifically designed to solve this problem. Patients enter their medication, dosage, and location. medfinder then contacts nearby pharmacies to identify which ones have the medication in stock and can fill the prescription. Results are delivered by text — no hold music, no repeated explanations.
Consider adding medfinder to your patient pre-op instructions as a resource for medication access difficulties. This reduces callbacks to your front office while improving patient satisfaction and compliance.
The Bottom Line
Nevanac access challenges are manageable with a proactive system. The highest-impact intervention is writing prescriptions 7–10 days ahead and identifying at-risk patients early. For a deeper clinical perspective on the availability landscape, see Nevanac Shortage: What Providers and Prescribers Need to Know in 2026.
Frequently Asked Questions
Send the Nevanac prescription at least 7–10 days before surgery, identify patients at high risk for access issues (uninsured, rural, elderly), and have alternative NSAID prescriptions ready to issue if Nevanac cannot be obtained. Direct patients to medfinder or GoodRx to identify available pharmacies.
Large chain pharmacies (CVS, Walgreens, Costco, Walmart), hospital outpatient pharmacies, and surgical center pharmacies tend to have the most reliable access to Nevanac. Consider creating a preferred pharmacy list specific to your practice's geographic area and sharing it with patients.
Generally, ophthalmology practices do not separately bill for prescription drug access counseling, but reducing medication access failures directly impacts surgical outcomes and patient satisfaction scores — which have downstream financial implications. Some practices include eye drop counseling as part of pre-surgical patient education.
Both Nevanac (nepafenac 0.1%, three times daily) and Ilevro (nepafenac 0.3%, once daily) contain the same active molecule and can help reduce macular edema risk in diabetic cataract patients. Ilevro's once-daily dosing may improve compliance. In the EU, nepafenac has an approved indication for reducing postoperative macular edema in diabetic patients; in the US this remains an off-label use. Consult current clinical guidelines and individualize based on patient risk.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Nevanac also looked for:
More about Nevanac
30,517 have already found their meds with Medfinder.
Start your search today.





